Skip to main content
Watch Insiders
RAINHealthcare

Rain Oncology Inc (RAIN) Insider Trading

In the last 90 days, 1 Rain Oncology Inc (RAIN) insider reported 1 open-market purchase totaling $104,225 and no sales. The most recent open-market purchase was reported on Aug 19, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$104,225
Corporate buyers
1
Latest transaction
Aug 19, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 19, 2026Randy SeidlChief Executive OfficerOpen Market Purchase110,000$0.95$104,225
May 22, 2025Randy SeidlChief Executive OfficerOpen Market Purchase42,514$2.37$100,949

Common questions

RAIN insider trading FAQ

Are RAIN insiders buying or selling?
Over the last 90 days, RAIN insiders were net buyers, reporting $104,225 of open-market purchases and $0.00 of sales.
When was the last RAIN insider purchase?
The most recent open-market purchase of Rain Oncology Inc stock by an insider was reported on Aug 19, 2026, one of 1 purchase in the last 90 days.
Where does RAIN insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Rain Oncology Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.